Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes - Concepedia

Concepedia

Publication | Closed Access

Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes

136

Citations

26

References

2008

Year

Paul S. Covington, Ronald Christopher, Miles P. Davenport, P. Fleck, Qais Mekki, Elisabeth R. Wann, Aziz Karim

Clinical Therapeutics

Diabetes ManagementDiabetesPharmacologyType 2Multiple-dose StudyTolerability ProfilesPharmacotherapyDiabetes MellitusMedicine

References

	Year	Citations

Page 1